Pricing and Market Access Considerations for Cell and Gene

An Overview of Cell and Gene Therapies

Two Labs Acquires CEEK Enterprises

Two Labs Acquires CEEK Enterprises

What manufacturers need to know about Minnesota House Bill 400

New regulation requirements impacting your license

Current and Future Oncology Management in the United States

Originally posted by the Journal of Managed Care & Specialty Pharmacy
Volume 25 Issue (2)
Anne Runyan, BA; Jordan Banks, MPA; and Daniele Severi Bruni, MS
MKO Global Partners, Powell, Ohio.
Abstract
BACKGROUND:
Current and Future Oncology Management in the United States

Innovative Access Agreements

NHS England targeting £150 million in savings through rapid adoption of biosimilar adalimumab

With the recent patent expiry of Humira® (adalimumab) in Europe, NHS England last week published a press release reiterating their goal of realizing £300 million in annual savings through the adoption of best value biologic medicines (originator or biosimilar) by … ...